Simplex Trading’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,100
| Closed | -$1K | – | 9970 |
|
|
2024
Q4 | $1K | Buy |
6,100
+1,100
| +22% | +$1.32K | ﹤0.01% | 8360 |
|
|
2024
Q3 | $10K | Sell |
5,000
-800
| -14% | -$2.87K | ﹤0.01% | 7218 |
|
|
2024
Q2 | $29K | Buy |
+5,800
| New | +$30.5K | ﹤0.01% | 6595 |
|
|
2024
Q1 | – | Sell |
-182,500
| Closed | -$7K | – | 10152 |
|
|
2023
Q4 | $7K | Sell |
182,500
-600
| -0.3% | -$2.06K | ﹤0.01% | 7709 |
|
|
2023
Q3 | $723K | Buy |
183,100
+900
| +0.5% | +$3.37K | ﹤0.01% | 3008 |
|
|
2023
Q2 | $573K | Hold |
182,200
| – | – | ﹤0.01% | 3161 |
|
|
2023
Q1 | $486K | Sell |
182,200
-14,900
| -8% | -$57.8K | ﹤0.01% | 3296 |
|
|
2022
Q4 | $707K | Sell |
197,100
-8,000
| -4% | -$34.7K | ﹤0.01% | 2820 |
|
|
2022
Q3 | $1.32M | Buy |
205,100
+204,870
| +89,074% | +$1.66M | ﹤0.01% | 2350 |
|
|
2022
Q2 | $2K | Sell |
230
-90
| -28% | -$842 | ﹤0.01% | 9456 |
|
|
2022
Q1 | $3K | Hold |
320
| – | – | ﹤0.01% | 9763 |
|
|
2021
Q4 | $10K | Sell |
320
-830
| -72% | -$33.6K | ﹤0.01% | 9069 |
|
|
2021
Q3 | $65K | Buy |
1,150
+10
| +0.9% | +$488 | ﹤0.01% | 7197 |
|
|
2021
Q2 | $62K | Buy |
1,140
+1,128
| +9,400% | +$66.8K | ﹤0.01% | 7392 |
|
|
2021
Q1 | $86K | Sell |
12
-17
| -59% | -$1.77K | ﹤0.01% | 5953 |
|
|
2020
Q4 | $318K | Buy |
+29
| New | +$2.65K | ﹤0.01% | 3991 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$114 | – | 7476 |
|
|
2020
Q2 | $8K | Sell |
1
-2
| -67% | -$180 | ﹤0.01% | 6780 |
|
|
2020
Q1 | $16K | Hold |
3
| – | – | ﹤0.01% | 6149 |
|
|
2019
Q4 | $18K | Buy |
+3
| New | +$182 | ﹤0.01% | 6039 |
|
|
2018
Q3 | – | Sell |
-2
| Closed | -$16K | – | 8209 |
|
|
2018
Q2 | $16K | Buy |
+2
| New | +$248 | ﹤0.01% | 6052 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5076 |
|
Simplex Trading's SYRS Position: Q2 2025 in Review
Simplex Trading sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2025, closing a stake of 4,123 shares.
Simplex Trading first reported a position in SYRS in Q4 2017 and held it in 20 quarters. The position peaked at $255K in Q3 2021. 0 funds tracked by Wall St. Rank hold SYRS as of Q2 2025.
- Simplex Trading reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 4,123 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2025.
- Simplex Trading first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
- Simplex Trading's Syros Pharmaceuticals, Inc. Common Stock position peaked at $255K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.